Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 104 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1031 11.2 months Malignant Pleural Mesothelioma 4 Chemotherapy
National Kyushu Cancer Center Japan 8/2014
Treatment Details: Patients: This study involved 17 malignant pleural mesothelioma patients who had previously been treated with pemetrexed and platinum chemotherapy agents. The median patient age was 58 yea
 
1032 11.2 months NHL 3 Biologic therapy
Chemotherapy
Shan Dong Tumor Hospital China 1/2015
Treatment Details: Patients: This study involved 27 previously treated primary central nervous system lymphoma patients. The median patient age was 53.5 years and 62.9% were male. Treatment: Patients rec
 
1033 11.2 months Metastatic, castration-resistant prostate cancer 5 Biologic therapy
Radiation
Mayo Clinic United States 5/2014
Treatment Details: Patients: This phase 3 study involved metastatic castration-resistant prostate cancer patients with bone metastases who had received prior treatment with docetaxel. Patients were divided i
 
1034 11.2 months Urothelial cancer 4 Biologic therapy
Chemotherapy
Alexianer Hospital Maria Hilf GmbH Germany 3/2014
Treatment Details: Patients: This phase 2 study involved advanced or metastatic urothelial cancer patients who were separated into two different treatment groups. Group A consisted of 49 patients with a medi
 
1035 11.2 months Metastatic colorectal carcinoma 5 Biologic therapy
Chemotherapy
Institut de Cancérologie de l'Ouest France 1/2013
Treatment Details: Patients: This phase 3 study involved metastatic colorectal cancer patients, previously treated with bevacizumab and chemotherapy, who were divided into two separate treatment groups. Ther
 
1036 11.2 months Malignant pleural mesothelioma 4 Chemotherapy
National Kyushu Cancer Center Japan 10/2013
Treatment Details: Patients: This phase 2 study involved 17 malignant pleural mesothelioma patients who had previously been treated with pemetrexed and platinum-based chemotherapy. The median patient age was
 
1037 11.2 months Metastatic breast cancer 5 Biologic therapy
Chemotherapy
The Ohio State University Comprehensive Cancer Center United States 7/2012
Treatment Details: Patients: This phase 2 study involved 22 metastatic breast cancer patients who had received prior taxane-based chemotherapy. The median patient age was 56 years. Treatment: Patients we
 
1038 11.2 months Castration-resistant prostate cancer 5 Chemotherapy
START Center for Cancer Care United States 4/2012
Treatment Details: Patients: This study involved 35 castration-resistant prostate cancer patients who had previously been treated with taxane-based chemotherapy. The median patient age was 67 years. Treat
 
1039 11.2 months Metastatic, castration-resistant prostate cancer 4 Biologic therapy
Chemotherapy
Wayne State University United States 2/2013
Treatment Details: Patients: This phase 2 study involved 31 metastatic castrate-resistant prostate cancer patients who had been previously treated with docetaxel. The median patient age was 67 years. Trea
 
1040 11.1 months Metastatic melanoma 5 Chemotherapy
Mayo Clinic United States 4/2011
Treatment Details: Patients: This phase 2 study involved metastatic melanoma patients who were divided into two separate groups. Group A had 34 previously treated patients with a median age of 60 years and 6
 
Page 104 of 187  | Previous Page  | Next Page